OBJECTIVE: To measure intrapericardial fat (IPF), extrapericardial fat (EPF), and myocardial perfusion (MBF) in patients with and without coronary artery disease (CAD), hypothesizing that perfusion is more strongly associated with IPF because it is in direct anatomic contiguity with the myocardium or coronary arteries. METHODS AND RESULTS: Fat surrounding the heart may increase the risk of CAD and calcification, but little is known about the role of MBF in this relationship. The study included 107 patients with an intermediate likelihood of CAD. Positron emission tomography/computed tomography was used to measure IPF and EPF volumes and coronary artery calcium level, together with MBF at rest and during adenosine-induced hyperemia. Subsequently, all subjects underwent coronary angiography and were grouped for presence/absence of CAD and severity of myocardial hypoperfusion. IPF and EPF levels were higher in men and in patients with CAD (n=85) than in those without CAD (n=22) (P<0.001). EPF was increased regardless of the degree of stenoses (n=45), whereas IPF was selectively increased in subjects with obstructive stenoses (n=40). IPF and EPF levels were both associated with coronary artery calcium scores (R=0.25 and R=0.26, respectively; P<0.02), coronary flow reserve (R=-0.37 and R=-0.38, respectively; P<0.001), and hyperemic MBF (R=-0.36 and R=-0.44, respectively; P<0.0005). Male sex was a strong negative predictor of MBF. After discounting for confounders, myocardial hyperemic perfusion was predicted independently by sex, coronary artery calcium score, and IPF, but not EPF. CONCLUSIONS: CAD is accompanied by augmented fat depots surrounding the heart, which are negatively related to coronary flow hyperemia. Among fat depots, IPF was the only independent predictor of hyperemic MBF, supporting the hypothesis of a direct paracrine/vasocrine effect.
OBJECTIVE: To measure intrapericardial fat (IPF), extrapericardial fat (EPF), and myocardial perfusion (MBF) in patients with and without coronary artery disease (CAD), hypothesizing that perfusion is more strongly associated with IPF because it is in direct anatomic contiguity with the myocardium or coronary arteries. METHODS AND RESULTS: Fat surrounding the heart may increase the risk of CAD and calcification, but little is known about the role of MBF in this relationship. The study included 107 patients with an intermediate likelihood of CAD. Positron emission tomography/computed tomography was used to measure IPF and EPF volumes and coronary artery calcium level, together with MBF at rest and during adenosine-induced hyperemia. Subsequently, all subjects underwent coronary angiography and were grouped for presence/absence of CAD and severity of myocardial hypoperfusion. IPF and EPF levels were higher in men and in patients with CAD (n=85) than in those without CAD (n=22) (P<0.001). EPF was increased regardless of the degree of stenoses (n=45), whereas IPF was selectively increased in subjects with obstructive stenoses (n=40). IPF and EPF levels were both associated with coronary artery calcium scores (R=0.25 and R=0.26, respectively; P<0.02), coronary flow reserve (R=-0.37 and R=-0.38, respectively; P<0.001), and hyperemic MBF (R=-0.36 and R=-0.44, respectively; P<0.0005). Male sex was a strong negative predictor of MBF. After discounting for confounders, myocardial hyperemic perfusion was predicted independently by sex, coronary artery calcium score, and IPF, but not EPF. CONCLUSIONS: CAD is accompanied by augmented fat depots surrounding the heart, which are negatively related to coronary flow hyperemia. Among fat depots, IPF was the only independent predictor of hyperemic MBF, supporting the hypothesis of a direct paracrine/vasocrine effect.
Authors: Yutaka Tanami; Masahiro Jinzaki; Satoru Kishi; Matthew Matheson; Andrea L Vavere; Carlos E Rochitte; Marc Dewey; Marcus Y Chen; Melvin E Clouse; Christopher Cox; Sachio Kuribayashi; Joao A C Lima; Armin Arbab-Zadeh Journal: Circ Cardiovasc Imaging Date: 2015-03 Impact factor: 7.792
Authors: Mohammed S Alam; Rachel Green; Robert de Kemp; Rob S Beanlands; Benjamin J W Chow Journal: J Nucl Cardiol Date: 2013-06-08 Impact factor: 5.952
Authors: Vincent Dunet; François Feihl; Amin Dabiri; Gilles Allenbach; Bernard Waeber; Raphaël Heinzer; John O Prior Journal: Eur J Nucl Med Mol Imaging Date: 2015-08-19 Impact factor: 9.236
Authors: Tina E Brinkley; Michael Jerosch-Herold; Aaron R Folsom; J Jeffrey Carr; W Gregory Hundley; Matthew A Allison; David A Bluemke; Gregory L Burke; Moyses Szklo; Jingzhong Ding Journal: PLoS One Date: 2011-12-09 Impact factor: 3.240
Authors: Jan Bucerius; Venkatesh Mani; Stephanie Wong; Colin Moncrieff; David Izquierdo-Garcia; Josef Machac; Valentin Fuster; Michael E Farkouh; James H F Rudd; Zahi A Fayad Journal: Eur J Nucl Med Mol Imaging Date: 2014-01-18 Impact factor: 9.236
Authors: M J Bakkum; I Danad; M A J Romijn; W J A Stuijfzand; R M Leonora; I I Tulevski; G A Somsen; A A Lammertsma; C van Kuijk; A C van Rossum; P G Raijmakers; P Knaapen Journal: Eur J Nucl Med Mol Imaging Date: 2015-06-09 Impact factor: 9.236
Authors: Lixian Sun; Cuiqing Liu; Xiaohua Xu; Zhekang Ying; Andrei Maiseyeu; Aixia Wang; Katryn Allen; Ryan P Lewandowski; Lori A Bramble; Masako Morishita; James G Wagner; J Dvonch; Zhichao Sun; Xiaowei Yan; Robert D Brook; Sanjay Rajagopalan; Jack R Harkema; Qinghua Sun; Zhongjie Fan Journal: Part Fibre Toxicol Date: 2013-08-22 Impact factor: 9.400